Dong-Wook Kang, Jae-Gyun Choi, Hee Ju Song, Jaehyuk Kim, Miae Lee, Taehee Kim, Suk-Yun Kang, Yeonhee Ryu, Hwa Seung Yoo, Jin Sun Lee, Jin Bong Park, Sang Do Lee, Hyun-Woo Kim
{"title":"正中神经刺激对化疗引起的周围神经病小鼠的镇痛效果以及脑源性神经营养因子表达的调节作用","authors":"Dong-Wook Kang, Jae-Gyun Choi, Hee Ju Song, Jaehyuk Kim, Miae Lee, Taehee Kim, Suk-Yun Kang, Yeonhee Ryu, Hwa Seung Yoo, Jin Sun Lee, Jin Bong Park, Sang Do Lee, Hyun-Woo Kim","doi":"10.19852/j.cnki.jtcm.2023.04.005","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Chemotherapeutic agents such as docetaxel (DTX) can trigger chemotherapy-induced peripheral neuropathy (CIPN), which is characterized by unbearable pain. This study was designed to investigate the analgesic effect and related neuronal mechanism of low-frequency median nerve stimulation (LFMNS) on DTX-induced tactile hypersensitivity in mice.</p><p><strong>Methods: </strong>To produce CIPN, DTX was administered intraperitoneally 4 times, once every 2 d, to male ICR mice. LFMNS was performed on the wrist area, and the pain response was measured using von Frey filaments on both hind paws. Western blot and immunofluorescence staining were performed using dorsal root ganglion and spinal cord samples to measure the expression of brain-derived neurotrophic factor (BDNF).</p><p><strong>Results: </strong>Repeated LFMNS significantly attenuated the DTX-induced abnormal sensory response and suppressed the enhanced expression of BDNF in the DRG neurons and spinal dorsal area.</p><p><strong>Conclusions: </strong>LFMNS might be an effective non-pharmaceutical option for treating patients suffering from CIPN regulating the expression of peripheral and central BDNF.</p>","PeriodicalId":17450,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"43 4","pages":"686-694"},"PeriodicalIF":0.0000,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320447/pdf/JTCM-43-4-686.pdf","citationCount":"0","resultStr":"{\"title\":\"Analgesic efficacy of median nerve stimulation in mice with chemotherapy-induced peripheral neuropathymodulation of brain-derived neurotrophic factor expression.\",\"authors\":\"Dong-Wook Kang, Jae-Gyun Choi, Hee Ju Song, Jaehyuk Kim, Miae Lee, Taehee Kim, Suk-Yun Kang, Yeonhee Ryu, Hwa Seung Yoo, Jin Sun Lee, Jin Bong Park, Sang Do Lee, Hyun-Woo Kim\",\"doi\":\"10.19852/j.cnki.jtcm.2023.04.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Chemotherapeutic agents such as docetaxel (DTX) can trigger chemotherapy-induced peripheral neuropathy (CIPN), which is characterized by unbearable pain. This study was designed to investigate the analgesic effect and related neuronal mechanism of low-frequency median nerve stimulation (LFMNS) on DTX-induced tactile hypersensitivity in mice.</p><p><strong>Methods: </strong>To produce CIPN, DTX was administered intraperitoneally 4 times, once every 2 d, to male ICR mice. LFMNS was performed on the wrist area, and the pain response was measured using von Frey filaments on both hind paws. Western blot and immunofluorescence staining were performed using dorsal root ganglion and spinal cord samples to measure the expression of brain-derived neurotrophic factor (BDNF).</p><p><strong>Results: </strong>Repeated LFMNS significantly attenuated the DTX-induced abnormal sensory response and suppressed the enhanced expression of BDNF in the DRG neurons and spinal dorsal area.</p><p><strong>Conclusions: </strong>LFMNS might be an effective non-pharmaceutical option for treating patients suffering from CIPN regulating the expression of peripheral and central BDNF.</p>\",\"PeriodicalId\":17450,\"journal\":{\"name\":\"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan\",\"volume\":\"43 4\",\"pages\":\"686-694\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320447/pdf/JTCM-43-4-686.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.19852/j.cnki.jtcm.2023.04.005\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19852/j.cnki.jtcm.2023.04.005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
目的多西他赛(DTX)等化疗药物可诱发以难以忍受的疼痛为特征的化疗诱导性周围神经病变(CIPN)。本研究旨在探讨低频正中神经刺激(LFMNS)对 DTX 诱导的小鼠触觉过敏的镇痛效果及相关神经元机制:雄性 ICR 小鼠腹腔注射 DTX 4 次,每 2 d 一次,以产生 CIPN。在腕部进行 LFMNS,并在两只后爪上使用 von Frey 灯丝测量疼痛反应。使用背根神经节和脊髓样本进行 Western 印迹和免疫荧光染色,以测量脑源性神经营养因子(BDNF)的表达:结果:重复LFMNS能显著减轻DTX诱导的异常感觉反应,并抑制DRG神经元和脊髓背区BDNF的表达:LFMNS可调节外周和中枢BDNF的表达,是治疗CIPN患者的一种有效的非药物疗法。
Analgesic efficacy of median nerve stimulation in mice with chemotherapy-induced peripheral neuropathymodulation of brain-derived neurotrophic factor expression.
Objective: Chemotherapeutic agents such as docetaxel (DTX) can trigger chemotherapy-induced peripheral neuropathy (CIPN), which is characterized by unbearable pain. This study was designed to investigate the analgesic effect and related neuronal mechanism of low-frequency median nerve stimulation (LFMNS) on DTX-induced tactile hypersensitivity in mice.
Methods: To produce CIPN, DTX was administered intraperitoneally 4 times, once every 2 d, to male ICR mice. LFMNS was performed on the wrist area, and the pain response was measured using von Frey filaments on both hind paws. Western blot and immunofluorescence staining were performed using dorsal root ganglion and spinal cord samples to measure the expression of brain-derived neurotrophic factor (BDNF).
Results: Repeated LFMNS significantly attenuated the DTX-induced abnormal sensory response and suppressed the enhanced expression of BDNF in the DRG neurons and spinal dorsal area.
Conclusions: LFMNS might be an effective non-pharmaceutical option for treating patients suffering from CIPN regulating the expression of peripheral and central BDNF.